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Endopolyploidyandgenomicinstabilityare sharedfeaturesofbothstress-inducedcellular senescenceandmalignantgrowth.Here,
we examined these facets in the widely used normal human ﬁbroblast model of senescence, IMR90. At the presenescence stage,
a small (2–7%) proportion of cells overcome the 4n-G1 checkpoint, simultaneously inducing self-renewal (NANOG-positivity),
the DNA damage response (DDR; γ-H2AX-positive foci), and senescence (p16inka4a- and p21CIP1-positivity) signalling, some
cells reach octoploid DNA content and divide. All of these markers initially appear and partially colocalise in the perinucleolar
compartment. Further, with development of senescence and accumulation of p16inka4a and p21CIP1, NANOG is downregulated
in most cells. The cells increasingly arrest in the 4n-G1 fraction, completely halt divisions and ultimately degenerate. A positive
link between DDR, self-renewal, and senescence signalling is initiated in the cells overcoming the tetraploidy barrier, indicating
that cellular and molecular context of induced tetraploidy during this period of presenescence is favourable for carcinogenesis.
1.Introduction
Cellular senescence is a condition in which the cells remain
a l i v eb u ta r eu n a b l et op r o l i f e r a t e .P r e m a t u r es e n e s c e n c ec a n
be triggered by certain stresses independently of the number
of cell divisions or telomere length [1], possibly as a result of
protracted DNA damage signalling [2]. Oncogene-induced
senescence is thought to behave similarly, driven at the very
e a r l ys t a g e so ft u m o u rd e v e l o p m e n tw h e r ei ts e r v e sa sa
barrier to cancer progression [3]. Subsequent progression
to full-blown malignancy is favoured when tumour stem
cells acquire further mutations that impair the senescence
pathway, for example, mutations in TP53 or CDKN2a [4, 5].
During in vitro culture, human ﬁbroblast cells undergo
a presenescence phenomenon whereby they display evidence
ofchromosomeinstability(CIN)withinanapparentlyhighly
heterogenous population with signs of chromosomal dam-
age, and the appearance of polyploid interphase cells and
their divisions [4, 6–12]. Whereas the frequency of diploid
mitotic cells at presenescence is declining, the number of
polyploidmitosesincreasestoapeakbeforeasharpfall asthe
cells change to the characteristic ﬂat morphology indicative
of replicative senescence [13, 14]. These data stimulated the
hypothesis that telomeric loss at senescence may represent a
“genetictimebomb”causallyinvolvedinbothcellsenescence
and malignant transformation [13, 15].
In is clear that CIN associated with polyploidy at the
presenescence stagemay substantially increase themutability
and risk of malignant transformation [16–18]. Moreover,
there are reports from normal cell cultures of revertant cells
escaping senescence by acquiring mutations [19]a n dt h e i r
ability to depolyploidise and restart mitoses [9–12, 17]. The
features of CIN, including polyploidy, are also characteristic
of malignant tumors where the degree of CIN is correlated
with aggression [20]. Induced endopolyploidy is a typical
response of tumour cells with deﬁcient p53 function to
the action of DNA or spindle-damaging agents [21–24].
For a decade, it has been generally accepted that sublethal
genotoxic damage to cancer cells associated with anticancer
clinical modalities accelerates cellular senescence [1, 25],
with concomitant induction of polyploidy as a component.
However, we and others have recently shown that the
induction of endopolyploidy followed by arrest and subse-
quent slippage from a spindle checkpoint is accompanied2 Journal of Aging Research
Table 1: Antibodies: source and use.
Primary antibodies Secondary antibodies
(dilution, if not stated otherwise, 1:400)
Mouse monoclonalanti-hNANOG (N3038, Sigma) 1:75 Goat anti-mouse IgG-Alexa Fluor 488 (A31619, Invitrogen) or
594 (A31623, Invitrogen)
Rabbit polyclonal anti-hOCT4 (ab19857, Abcam) 1:200 Goat anti-rabbit-IgG-Alexa Fluor 594 (A31631, Invitrogen)
Goat polyclonal anti-hOCT3/4 (N-20) (sc-8630X, Santa Cruz) 1:400 Rabbit anti-goat IgG-Cy3 (C2821, Sigma) 1:500
Rabbit polyclonal anti-hP21 C-19 (sc-397, Santa Cruz) IF 1:50 Goat anti-rabbit-IgG- .Alexa Fluor 594 (A31631, Invitrogen)
Rabbit polyclonal anti-hP16 N-20 (sc-467, Santa Cruz) IF 1:50 Goat anti-rabbit-IgG- .Alexa Fluor 594 (A31631, Invitrogen)
Mouse monoclonalanti-hPML (sc-966, Santa Cruz) 1:150 Goat anti-mouseIgG-Alexa Fluor 488 (A31627, Invitrogen)
Rabbit polyclonal anti-hAURORA B (ab2254, Abcam) 1:300 Goat anti-rabbit-IgG- .Alexa Fluor 594 (A31631, Invitrogen)
Rabbit polyclonal anti-h-γH2AX (4411-PC-100, R&D Systems) 1:200 Goat anti-rabbit-IgG- .Alexa Fluor 594 (A31631, Invitrogen)
in p53-mutant tumour cells by the activation of meiotic
proteins [24, 26, 27] and key self-renewal transcription
factors (OCT4, NANOG, and SOX2) [28]. The majority
of these polyploid cells senesce. However, a minor fraction
retains divisional activities (thus counteracts or reverses
senescence), accumulate self-renewal factors in their sub-
nuclei, and subsequently undergo depolyploidisation to
paradiploid descendants that provide clonogenic regrowth
[28, 29].
Cycling tetraploidy, an illicit deviation from the normal
cell cycle, is considered to serve as a crucial step from
diploidy to cancer-related aneuploidy and from senescence
to malignancy [17, 30–32]. Together, these data highlight the
needtomorecloselyinvestigatetheroleofendopolyploidyin
the relationship between self-renewal and senescence. These
investigations will greatly assist the current endeavoursbeing
made to induce reprogramming of somatic cells that are
free from genomic damage and provide further information
regarding the use of senescence-induction as a potential
anticancer strategy [33, 34].
Therefore, we chose to examine these phenomena using
a well-established model of cell senescence, involving in vitro
cultured normal human ﬁbroblast IMR90 cells. We show
here that a small proportion of cells undergoing senescence
are able to overcome the tetraploidy barrier and that these
cells appear to simultaneously upregulate self-renewal and
senescent factors.
2.Materialsand Methods
2.1. Cell Culture. The wild-type p53 human embryo lung
ﬁbroblast cell line IMR90 was obtained from ATCC and
also from Coriell collection kindly donated by Dr. A.
Ivanov (Beatson Institute, Glasgow) after 21–23 population
doublings (PDL). Cells were cultured in DMEM (Sigma)
supplemented with 10% FBS (Sigma), without antibiotics,
as monolayers in a humidiﬁed incubator in 5% CO2/95%
air atmosphere. The early passage cells were split 1:3 (∼50
× 104 of cells per ﬂask (25cm2) twice weekly. Mid-passage
cells were split 1:2 weekly, and late-passage cultures were
split 1:2 once culturesattained conﬂuence. Culture medium
was changed two or three times between subculture. In this
way, several subsequent passages were carried out until the
cells failed to undergo >0.8 population doublings in a 7-day
cultureperiod. Underthe givenconditionsofcultivation,the
cells typically reached this state after 40–50PDL.
2.2. Immunoﬂuorescence (IF). Cells were trypsinized, pel-
leted, washed in warm PBS, resuspended in FBS and
cytospun on to polylysine-coated slides. For detailed cyto-
logical studies, the cells were also grown on glass cover
slips. Cells on coverslips were rinsed in PBS and FBS, then
ﬁxed in methanol at −20◦Cfor7min(30minforγ-H2AX
staining) followed by 10 short rinses in cold acetone at
−20◦C. Slides were washed in TBS/0.01% Tween-20 (TBST)
(0.05% Tween-20 for γ-H2AX staining) three times for
5min each, after which they were blocked with 1% bovine
serum albumin in TBS/0.05% Tween-20 for 15min. Fifty
microliters of the appropriate dilution of antibody was
applied to each sample and the slides incubated overnight
at 4◦C. Samples were washed thrice for 5min each time
in TBST. The sources and dilutions of the primary and
secondary antibodies are listed in Table 1. Poststaining was
with DAPI (0.25μg/mL). Cells were ﬁnally embedded in
Prolong Gold (Invitrogen).
2.3. Microscopy. A ﬂuorescence microscope (Leitz, Ergolux
L03-10) equiped with a colour videocamera (Sony DX-
S500) was used to examine cell preparations, record images,
and perform image cytometry. For three-colour images and
colocalisation studies, the BRG ﬁlter system (Leica) provid-
ing nonoverlapping excitation and transmission emission of
blue, red, and green bands was used. In addition, confocal
microscopy (Leica, DM 600) was used with the images
scanned in the three diﬀerent colour channels in sequence.
2.4. DNA Image Cytometry. Cells grown on coverslips were
rinsed in PBS and serum. Alternatively trypsinised cells
were washed in warm PBS and suspended in FBS and
cytospun onto glass slides. Both preparations were then
ﬁxed in ethanol/acetone (1:1, v/v) overnight at 4◦Ca n d
air dried. For stoichiometric DNA staining [35], slides were
hydrolysed with 5N HCl for 20min and stained with 0.05%
toluidine blue in McIlvain 50% buﬀer pH 4 for 10min
at room temperature, rinsed, dehydrated in warm butanol,Journal of Aging Research 3
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Figure 1: Phenotypic characteristics of IMR90 in the process of senescing showing cell enlargement and the accumulation of principal
growth inhibitors involved in the regulation of senescence, p16 and p21, in three stages: ((a), (d)) presenescence, ((b), (e)) senescence, ((c),
(f)) degeneration phase. ((a)–(c)) p16 (red) and DAPI (blue); ((d)–(f)) p21(red) and DAPI (blue). Scale bar = 20μm.
and passed through xylene prior to embedding in DPX
(Sigma-Aldrich). DNA content was measured as the integral
optical density in 200 cell nuclei in the green channel of the
calibrated video camera, using Image Pro Plus 4.1 software
(Media Cybernetics; REO 2001, Latvia). In parallel, optical
density and nuclear area were registered. The estimated sum
of device and measurement error was <5%. The 2C DNA
content was determined by the modal value of the ﬁrst G1
peak. Mitotic indices were counted per 1,000–2,000 cells in
the same samples.
2.5. RNA Extraction, RT-PCR, and DNA Sequencing of
NANOG. These studies were performed on IMR90 cells in
a logarithmic phase of growth as described before [28].
3.Results
3.1. Kinetics and Characteristics of Senescing Cells. Subcul-
tivation of IMR90 cells invariably leads to diminishing
growth after a number of passages. Under our experimental
conditions, this was reached prematurely at passage 32–34
corresponding to 40–50PDL. This was likely due to growing
the cells in the air atmosphere shortening their lifespan [36].
During further passaging, full growth arrest was achieved,
characterised by the mitotic index reaching zero and the cells
attaining typical features of senescence such as cytoplasm
enlargement and ﬂattening and bi- and multinuclearity, as
well as accumulation of senescence markers p16inka4a (p16)
and p21inka4a (p21) as illustrated on Figures 1(a), 1(b),
1(d),a n d1(e). Degenerative phase was characterised by
nuclear swelling and cell lysis (Figures 1(c) and 1(f)).
3.2. DNA Cytometry Reveals a Minor Fraction of Cycling
Tetraploid Cells. As the cells underwent this senescence
phenomenon, they were analysed by DNA image cytometry
in three independent experimental series. The following
cytometric regularities were observed. In the stage of loga-
rithmic growth (typiﬁed in Figure 2(a)), where the mitotic
index was 4.5–3.0%, the cell population had a normal
cell cycle, with typical DNA distribution of the major
fractions between 2C and 4C. During presenescence, with
the mitotic indices progressively lowering, the histogram
of DNA distribution remained generally similar (exampled
on Figure 2(b)), however the proportion of cells in the
G1-2C phase increased and the S-phase decreased. At
senescence, where no mitoses were observed, the proportion
of interphase cells in the 4C-fraction was again increased
(Figure 2(d)). This change was already noticeable at late
presenescence, one-two passages earlier (Figure 2(c)). The
average proportions of 4C cytometric fractions at the stages
of logarithmic growth, presenescence and senescence, and
corresponding proportions of the cells with p21-positive
nuclei are presented on Figure 3.
In addition to the major DNA cytometric fractions, we
also observed a small proportion (1–7%) of hypertetraploid
cells, some of them reaching octoploidy. The number of
hypertetraploid cells strongly inversely correlated with
mitotic indices in each experimental series (Figure 4(a)).
Furthermore, the number of octoploid cells was found4 Journal of Aging Research
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Figure 2: Histograms of IMR90 DNA content in several passages showing typical changes in the time course: (a) logarithmic growth,
(b) presenescence, (c) late presenescence, and (d) senescence showing the accumulation of 4C cells and the increase of the proportion of
hypertetraploid cells, some of which reach octoploidy.
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Figure 3: Quantitative data showing changes obtained from the
DNA cytometry results, at the growth phase, presenescence, and
senescence averaged from all experiments and the corresponding
proportionsofcells displayingnuclearpositivityforp21.Signiﬁcant
increase of the 4C fraction accompany transition from presenes-
cence to senescence (P = .015). Increase of the proportion of
hypertetraploid cells, in parallel to considerable increase of the
proportion of p21-positive cells, accompany the whole process.
increasing with hypertetraploidy (Figure 4(b) and can be
seen from Figure 2). These data indicate that the process
of (accelerated) senescence encourages the cells to leave the
normal cell cycle favouring their cycling as tetraploids.
3.3. Self-Renewal Markers Appear at Presenescence in Tetrap-
loid Cells Simultaneously with Senescence and DDR Markers.
We were further interested to see the association of these
polyploid features with DDR, self-renewal, and senescence
markers. At presenescence, we found that the embryonal
transcription factors of pluripotency and self-renewal OCT4
(mostly cytoplasmic) and NANOG (nuclear) were activated
in parallel with the initial activation of senescence factors in
the same cells. Notably, this occurred in the cells with larger
nuclei and larger (often polygonal) p16-positive cytoplasm,
suggesting that these were hypertetraploid cells which had
initiated the process towards senescence (illustrated in
Figure 5). In an eﬀort to better characterise the position of
theseparticularcellsinthecellcycle,weundertooktwokinds
of analysis.
First, we stained samples stoichiometrically with Tolui-
dine blue for DNA and recorded the integral optical density
(DNA content), nuclear area, and subsequently optical den-
sity (OD, concentration of DNA) of 200 cells in each sample
using Image Pro Plus software. Importantly, this imaging
method is interactive and excludesany cell aggregates, which
are either excluded or separated for single cells before the
measurement by the operator. Using this approach, the
concentration of DNA remained constant in all samples (the
data are not shown), with dispersion of OD around the
average within only 2-3%, up to the degeneration phase. The
positive correlation between the DNA content per nucleus
and its area counted for each sample is high (r = 0.57–0.76);Journal of Aging Research 5
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Figure 4: Tetraploidy increases in the course of IMR90 senescence. (a) The number of hypertetraploid cells increases with senescence and
strongly inversely correlates with mitotic indices in each experimental series; (b) the number of cells with octoploid DNA content increases
with hypertetraploidy indicating to increase of tetraploid cycling (the united data from three experiments).
OCT4 NANOG DNA
(a)
NANOG DNA p16
(b)
Figure 5: Examples of pre-senescent IMR90 ﬁbroblasts grown on the coverslip, which diﬀer from the surrounding cells by enlarged nuclei,
cytoplasm volume, and the tendency of ﬂattening. These cells express: (a) enhanced OCT4 (mostly in cytoplasm) and nuclear NANOG and
(b) paranucleolarlylocalized NANOG, which is combinedwith enhanced expression of the senescenceregulator, p16. Both, self-renewal and
senescenceregulators are undetectable oratthe backgroundlevel in theneighbouring ﬁbroblastspossessingsmallnuclei. Scalebars = 10μm.
On (a) OCT4 was stained with the antibody for both A and B isoforms(Abcam polyclonalantibody, see Table 1).
an example is shown in Figure 6(a).T h i sc o n ﬁ r m st h e
accepted observation that nuclear area is proportional to
DNA content; hence, its concentration remains constant
[37, 38]. In Figure 6(a), sampled from presenescence phase,
it is seen that the nuclear size of the 4C nuclei cluster
is roughly twice as large as that of the 2C nuclei cluster,
while the nuclear size of the cells with hypertetraploid DNA
content exceeds that of the average 4C nuclei. It follows
that the cells with a nuclear area visibly larger than that for
G1 and G2 cells should contain the hypertetraploid DNA
content.
Second, we stained samples for NANOG and one of the
mainsenescenceregulators(p16orp21)incombinationwith
DAPI. Using this approach, we identiﬁed cells possessing
visibly larger nuclei as compared with G1- and G2-sized
nuclei of surrounding ﬁbroblasts which simultaneously
expressed markers of both self-renewal (NANOG) and
senescence. We subsequently applied DNA measurement
of the integral nuclear ﬂuorescence (INF) of these and
neighbouring cell nuclei as exempliﬁed on Figures 7(a) and
7(b), through 16 optical ﬁelds (total 242 cells); a selection
of seven microscopic ﬁelds is also presented in supplemental6 Journal of Aging Research
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Figure 6: The relationship between the nuclear area and the DNA content (IOD) per each cell nucleus in: (a) a typical sample of
presenescence phaseand (b) the comparison of the latter and a sample in the degeneration phase. It is seen that the nuclear size is increasing
roughly proportionally to the DNA content in the presenescence phase, while in the degeneration phase, the nuclear size is much larger
indicating to nuclear swelling.
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Figure 7: Examples of DNA content measurements by integral ﬂuorescence in the DAPI channel using Image Pro Plus software in
microscopic ﬁelds including cells with enlarged nuclei and stained for: ((a), (b)) NANOG, p16, and DNA by DAPI, ((c), (d)) Aurora B-
kinase and DNA by DAPI. The selected hyperoctoploid cell (∗) shown in (a) has an enlarged p16-positive cytoplasm and some amount of
both NANOG and p16 in the nuclear region, and this region is magniﬁed in the insertion; the paraoctoploid cell in (c) is positive for Aurora
B-kinase.Journal of Aging Research 7
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Figure 8: Mitoses of IMR90: (a) normal mitosis of a diploid cell in the growth stage, ((b)–(d)) mitoses in the presenescence stage. (b)
Anaphase of the tetraploid cell, chromosome bridge (arrowhead) indicates to CIN. (c) Metaphase of the large tetraploid cell (∼8C). (d) An
attempt of the tetrapolar mitosis indicating to CIN. ((a),(b))stoichiometric staining for DNA with Toluidine blue pH 4.0 after extraction of
RNA. ((c),(d)) Similar staining after partial extraction of RNA. Scale bar = 10μm.
Figures 1–6 in Supplementary Material available online
at doi: 10.4061/2011/103253. The standard error of such
nuclear measurements comparing the INF recorded on
the smallest cell nuclei (2C-G1) was around 20%. The
selected cells which expressed markers of self-renewal and
senescence contained tetraploid, hypertetraploid, or octo-
ploid amounts of DNA more frequently than surrounding
cells.
We were interested subsequently if these cells retained
proliferation capacity. Using immunostaining for Aurora B-
kinase as a marker of cell division potential for endopoly-
ploidcells[39],weoftenfoundthatcellswithenlargednuclei
containing the tetraploid or octoploid amounts of DNA
(as also detected in DAPI channel), were Aurora B-positive
(exempliﬁed on Figures 7(c) and 7(d)). At presenescence, we
also found mitoses of tetraploid cells. Although commonly
aberrant or pycnotic, some proceed to anaphase with signs
of CIN such as chromosome bridges or multipolar mitoses
(Figure 8).
The enlarged nuclei were also often labelled by the
DDR marker γ-H2AX coupled to the NANOG staining
(Figures 9(a) and 9(f)). Thus, at the presenescence stage, the
cells with enlarged nuclei possessing enlarged p16-positive
cytoplasm, simultaneously expressing small amounts of self-
renewal, senescence, and DDR markers in their nuclei were
foundtobetetraploid,hadovercomethe4n-G1 barrier, were
cycling to octoploidy, and possessed division potential.
3.4. Self-Renewal, DDR, and Senescence Markers Are Initially
Localised inthePerinucleolarCompartmentofTetraploid Cells.
Interestingly, manifestations of all three kinds of response
(γ-H2AX, NANOG, and p16/p21) were seen to be partialy
colocalised as foci detected by BRG three-band optical ﬁlter
(with nonoverlapping excitation and emission bands); and
conﬁrmed by confocal microscopy (supplemental Figure 7).
These concentrated in the perinucleolar compartment either
to one side of the large central nucleolus or surrounding
it (Figures 9(a)–9(c)). Initial signs of senescence-associated
heterochromatin foci (SAHF) also appear to emerge from
the perinucleolar chromatin in such cells (Figure 9(d)). The
initially observed PML-bodies, partially colocalised with
γ-H2AX -positive speckles, were also found in this area
(Figure 9(e)). The IMR90 cells at the logarithmic stage of
growth had very low background IF staining for NANOG
conﬁrmed by RT-PCR and DNA sequencing (data not
shown). The amount of NANOG usually seen by IF in8 Journal of Aging Research
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Figure 9: Characteristic cytological nuclear IF features of the tetraploid cells in the presenescence phase showing synergism of several
labels located near the nucleoli. (a) Initial DDR in the perinucleolar chromatin indicated by the γ-H2AX-positive label (arrowheads), NL-
nucleolus.(b) The accumulationofp16andNANOG-positive, partly colocalisinggranules inthe perinucleolar region (arrowheads).(c)The
accumulation of p21 and NANOG—partial colocalisation around the central nucleolus (arrowheads). (d) The emergence of initial gentle
SAHFs revealed by DNA-speciﬁc metachromatic stainingwith Toluidine-blue in the perinucleolar chromatin (arrowheads). (e) PML bodies
in the vicinity of the central lobulated nucleolus, where they partly colocalise with γ-H2AX-foci. (f) The tetraploid cell from the mid-
presenescence with the network of γ-H2AX and some amount of NANOG, partially colocalised. Images were obtained using BRG three-
colour optical ﬁlters system. Scale bars =10μm.
the enlarged cell nuclei at early presenescence exceeded the
background of surrounding cells with normal nuclei by ∼2–
4-fold (supplemental Figure 7).
We compared the frequency of this coexisting self-
renewal and senescence nuclear landmarks (mostly perin-
ucleolar) in the cells with enlarged nuclei with that in the
surrounding ﬁbroblasts possessing normal 2C–4C-sized cell
nuclei in one of early presenescence passages (Figure 11).
From these counts, it can be seen that initial DDR and
simultaneous senescence and self-renewal signalling were
found in 84–96% of the cells with enlarged nuclei at far
greater frequency (many-fold) than in the cells of the
normal cell cycle. It should be stressed that it was practically
impossible to ﬁnd at this stage the cells where the nuclear
enlargement and initial expression of DDR, NANOG, and
senescence landmarks were dissociated. As such, also this
approach conﬁrmed that the expression of key markers of
both senescence and pluripotency become selectively and
simultaneously activated in tetraploid cells.
3.5. Through Intermediate Stage, NANOG Is Gradually Lost
fromMostTetraploidCell Nuclei,Correlating withanAccumu-
lation of Senescence Markers during the Time Course of Senes-
cence. Development of the tetraploid cells in subsequent
passages of the culture as it progresses towards terminal
senescence is characterised by the shaping of clear SAHFs,
further increase of p16 in the enlarging cytoplasm, while
smaller was this increase in the nuclei, and much stronger
positivity of nuclear p21. p21 begins to extend from the
perinucleolarregionintothenucleoplasm(Figure 9(c)).Like
p21, γ-H2AX also forms an elaborate network mostly in
polyploid cells (Figure 9(f)). In these cells, NANOG can still
be found, albeit in a more disseminated form, sometimes
colocalised with regions of the p21 (Figure 9(c))a n dγ-
H2AX network (Figure 9(f)).
Figure 9(f) shows some intermediate state, when the both
markers are still expressed. However, in mid-presenescence
passages, γ-H2AX vanishes from the cells with the stronger
expression of NANOG, and contrary to that, 2-3% of cellsJournal of Aging Research 9
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Figure 10: Relatively rare ﬂattening giant ﬁbroblasts displaying at presenescence a considerable accumulation of NANOG ﬁlling the whole
nucleus in parallel to clear DAPI-positive SAHFs; in addition, the cells contain p16-positive material in the cytoplasm.Images were obtained
using BRG three-colour optical ﬁlters system. Scale bars = 10μm.
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Figure 11: Proportions of the ﬁbroblasts with enlarged (hyperte-
traploidy) nuclei and with conventional small nuclei in the early
presenescence stage,estimated inoneofthesamplesby thelabelling
frequency for γ-H2AX (n = 400 cells), NANOG/p16 positive (n =
300 cells), and NANOG/p21-positive nuclear granules (n = 300
cells). All nuclear labels were mostly present in this phase in the
perinucleolar region. Evaluation reveals a many-fold prevailing sig-
nalling for DDR, self-renewal, and senescence regulators occurring
simultaneously in the enlarged hypertetraploidy cells, which left
normal cell cycle.
which develop very clear thick γ-H2AX foci do not contain
NANOG (not shown). The cells with large nuclei and
stronger expression of NANOG are more notable in the
“midpassages” of the presenescence (2–5%), a few may
accumulate it in their nuclei in the considerable amounts
(Figure 10). However, the main tendency towards further
senescing, contrary to the early phase of presenescence,
when the initial expression of self-renewal and senescence
markers appears positively linked,at more extended passages
the expression of NANOG in the giant nuclei generally de-
creases proportionally to the accumulation of cytoplasmic p16
and of the enhanced nuclear expression of p21, as illustrated
on Figure 12.
In the very last passages, approaching terminal senes-
cence with the mitotic index tending to zero (<0.1%), this
trend is further extended as illustrated in Figures 1(b), 1(c),
1(e),a n d1(f), where the giant polyploid cells with large
cytoplasm display considerable accumulation of p21 and
p16. They are void of the NANOG expression or contain
it at the background level. However, rare exceptions of the
NANOG-positive cells with the only background expression
ofsenescencefactorswereencountered(Figures12(d)–12(e),
arrowed). Further, the senescent cells appear to enter the
terminal degeneration phase. Figures 1(c) and 1(f) show the
appearance of cells at the terminal degeneration phase of
the senescent culture, sampled from one typical experiment.
These cells are characterised by the accumulation of p16
and p21 in the cell nuclei, absence of NANOG, lysis of the
cytoplasm (Figures 1(c) and 1(f)), and by swelling of the
nuclei as testiﬁed by DNA image cytometry presented in
Figure 6(b).
4.Discussion
Here, we have documented the cellular behaviour of IMR90
cells as they undergo senescence after protracted in vitro
culture. A notable observation in this process is the appear-
ance of tetraploid cells. Clearly, tetraploid cells appearing in
senescing cultures represent a deviation from normal cell
cycle regulation. Such cells and their aberrant proliferative
activities were reported from the very early studies of in vitro
senescing cultures of normal ﬁbroblasts occurring before
terminal arrest of proliferation [6–8] ,a n dc o n ﬁ r m e dm o r e
recently [10]. Our results are entirely in accord with them.10 Journal of Aging Research
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Figure 12: The antagonism between expression of NANOG and senescence regulators at the late presenescence and senescence phases:
((a)–(c)) late presenescence (MI = 0.1%): in the group of ten cells it is seen that nuclear staining of NANOG is found only in the cells with
enlarged nuclei, where NANOG staining intensity is inverse to the staining for p21; ((d), (e)) senescence (MI = 0)—a rare NANOG-positive
cell was encountered (arrowed), which has the weakest stainingfor p16 in its cytoplasm amongﬁve cells ofthe group. ((a),(d)) were imaged
through the BRG ﬁlter; ((b), (e))—through blue, and (c)—through green ﬁlter. Scale bars = 10μm.
These deviations, indicative of chromosomal instability
during presenescence, were shown to be related to telomeric
dysfunction [13–15, 40].
It is diﬃcult to judge to what extent the induction
of polyploidy is associated with the stress due to in vitro
cultivation. Previously, more stressful conditions of passage
were shown to have a slight increase in polyploidy induction,
although the same results could have been obtained, if
more laboriously, from unstressed cells [10]. On the whole,
our present data and that generated previously show that
in the senescing culture, there is a tendency for a small
proportionofnormalhumanﬁbroblaststoincreasinglyform
tetraploid cells, to cycle to octoploidy, and then divide.
Cycling tetraploidy is generally considered as a dangerous
steptowards carcinogenesis as it brings CIN and can result in
aneuploidy[30,32].Itisknownthatfunctionalp53/p21CIP1
should prevent tetraploidy at the 4n-G1/S checkpoint [41,
42], the existence of which was also disputed [16]. Our
DNA cytometric data showed that at presenescence, this
barrier is leaky and is linked to accumulation of 4C cells
during the senescence process as the cells approach full
growth arrest. The same increase in the 4C cell fraction in
senescing IMR90 cells, then interpreted as arrest at the 4n-
G1 checkpoint, was previously reported by Sherwood and
colleagues [43] following analysis by DNA ﬂow cytometry
and karyotyping and the same was found in an accelerated
senescence model of Ras-oncogene transfected IMR90 cells
[44].
In addition, we found here that illegitimate cycling of
tetraploid cells at the early presenescence phase was asso-
ciated with activation of the self-renewal response mani-
fested by expression of the embryonal transcription factor
NANOG. In our preliminary studies, we have also observed
that the OCT4B splicing form (POU5F1 B) was activated;
however, as its function is unknown, we concentrated here
mostly on studies of NANOG expression.
The homeodomain gene, NANOG, is a key intrinsic de-
terminant of self-renewal and pluripotency in embryonic
stem cells. Beside its transactivation function, NANOG was
also reported to directly propagate the G1-S transition by
ativating cdk6[45].Asthesenescenceregulator, p16prevents
endogenous Cdk6 and Cdk4 from associating with its
catalyticunit cyclinD1 [46], NANOGshould counteractthis
activity of p16. Moreover, normal embryonal stem cells in
response to damage were shown to upregulate self-renewal
transcription factors (Oct4 and Nanog) readily undergo-
ing mitotic slippage and reversible tetraploidy [47]. There-
fore, it remains possible that NANOG expression may forceJournal of Aging Research 11
the normal ﬁbroblasts (ortheirstem cells) in stressed senesc-
ing cultures to bypass this tetraploidy limiting control.
Our IF observations showed directly that NANOG is
expressed in tetraploid cells of pre-senescing cultures unless
the cells accumulate considerable amounts of senescence
regulators (which occurs increasing as the cultures approach
terminal senescence); in particular, clear antagonism was
foundatlatepassagesbetween NANOGandaccumulationof
nuclear p21. These observations are entirely in line with the
suggestionthatp16representsasecondbarriertosenescence,
which in the absence of the main barrier p53/p21 may be
reversible [48] .O u ro b s e r v a t i o n so nm o r ea c c u m u l a t i o n
of NANOG in some tetraploid cells, which lose the DDR
signalling in the intermediate presenescence stage, may be
cautiously interpreted as tendency to revert senescence.
It follows that at the presenescence phase, the amount
of the p53/p21 growth inhibitor appears insuﬃcient to
downregulate NANOG,which may to some extent neutralise
p16andthat,therefore,moretime(oractivationofmorep53
activatorsincludingforexample,thep38pathway[16,49])is
needed for p53 to become an eﬃcient enforcer of senescence
barrier. This explanation of ouro b s e r v a t i o n si si nl i n ew i t h
the data that activated p53 suppresses the NANOG gene
promoter [50].
Recently, Davoli and colleagues [40] showed that simul-
taneous elimination of telomerase and p53 causes chronic
DDR resulting in the prolonged G2 arrest and tetraploidis-
ation through licensing DNA rereplication origins. This data
also well ﬁt our observations as senescing is associated with
telomere dysfunction (however, induction of self-renewal
m a yc o u n t e r a c ti tb ya c t i v a t i n gt elomerase; this aspect needs
further research), while found delay of p21 accumulation
means relatively retarded activation of p53.
Although IMR90 are normal, nonmalignant cells con-
taining wild-type p53, our observations importantly show
for the ﬁrst time that these normal cells can temporarily
activate the self-renewal factor NANOG and enter “a win-
dow” when senescence regulators are as yet insuﬃciently
active to irreversibly neutralise its activities. In line with
this suggestion, upregulation of several embryonal pluripo-
tency and self-renewal factors have also been reported by
Riekstina and coauthors [51] in putative stem cells obtained
from explanted adult human mesenchymal tissues during
their ﬁrst adaptive passages of in vitro cultivation. The
step into tetraploidy is associated with DDR and genome
instability, known to greatly increase the probability of
chromosomalandgeneticmutationsandescapeofrevertants
[30]. The same concern was formulated by Romanov
et al. [19]a n dW a l e n[ 17], who showed that in presenes-
cence the tetraploid cells display depolyploidisation activi-
ties and can ultimately escape senescence with a mutated
genotype.
Although the IMR90 model is one of replicative or accel-
erated senescence in vitro, it has clearrelevance to pathologic
conditions in vivo where adult stem cells may be involved
such as chronic inﬂammation and/or trauma.
However, a puzzle remains for the seemingly simultane-
ous initial induction of the opposing responses of DDR, self-
renewal, and senescence in the early pre-senescent tetraploid
cells. The site of convergence may be the RAS-RAF-MEK-
ERK pathway priming both the mitogenic and accelerated
senescence pathways [52]. It was shown that moderate
activation of the wild-type Ras is mitogenic, while over-
expression causes p38-MAPK-dependent senescence [49].
This trigger leads, in particular, to positive versus negative
regulation of Cyclin D1 [53], the catalytic unit of cdk6
activated by Nanog [45]. In the negative loop, suppression of
NanogbyMEK-ERKwasshownthroughchemicalinhibition
of MEK [54]. Clearly, the impact of the MEK/ERK pathway
on NANOG and its role in the signalling of senescence
require further attention.
The data, somewhat supportive for our observations,
were reported by Banito and colleagues [55]w h os h o w e d
upregulation of cellular senescence by transduction in
IMR90 cells of the four pluripotency-inducing oncogenes.
Interestingly, all three kinds of the initial response, self-
renewal, DDR and senescence, were found spatially conﬁned
to the perinucleolar compartment, and their partial or full
colocalisation suggests a cross-talk between these pathways.
Moreover, it is likely that the SAHFs which represent regions
of epigenetically changed chromatin also start to form
from the same region of the perinucleolar chromatin and
are associated with the emergence of the DNA double-
strand breaks. The question is why these various aspects are
appearing in the nucleolus.
The nucleolus is involved in the regulation of senescence
in several ways. Nucleostemnin, a nucleolar protein speciﬁ-
cally involved in regulating the cell cycle in stem and tumour
cells, can sequestrate MDM2 and MDM4 and, thus, favour
accumulation of p53, the main player in senescence induc-
tion [56, 57]. Similarly nucleolar Arf will activate p53 in the
senescence response [58]. In addition, relocation of hTERT
to the nucleolus is associated with initiation of senescence
[59]. Finally, PML binds MDM2 and sequesters it into
the nucleolus [60], thus protecting p53 from proteosome-
mediated degradation.
However, the most important aspect may be that, in
eukaryotic systems, rDNA contains fragile sites that are
extremely sensitive to replication-induced stress [61, 62].
This replication stress may be related to the p53 independent
license of rereplication origins ﬁred at prolonged G2 arrest
[40]. The level of the DNAPolymerase I in IMR90 tetraploid
cells may be insuﬃcient at this time-point, causing stalling
of replication forks and converting the underreplicated sites
into rDNA strandbreaks [63]. This idea is compatible with
cancer development from its earliest stages being associated
with DNA replication stress, leading to DNA strandbreaks
and subsequentlyto DDR [3, 64, 65].
In relation to p53-function-deﬁcient tumours, our data
[28, 29] also show that endopolyploid cells induced after
genomic insult undertake sustainable activation of the
pluripotency and self-renewal genes, and undergo a stage
of competition between self-renewal and senescence with
an improved chance for self-renewal to succeed. A pro-
portion of these p53-mutated polyploid cells is capable of
accumulating considerable amounts of self-renewal factors
and subsequently depolyploidise into mitotic paradiploid
descendants.12 Journal of Aging Research
5.Conclusion
Our ﬁndings on senescing normal human IMR90 ﬁbroblasts
clearly provide us with insight into the risks of cancer
development.Sinceitisassumed thatacancerclonedevelops
from a single adult stem cell which receives a mutation(s),
including those compromising the senescence barrier, our
observations suggest that this may be favoured in the normal
stressed tissue due to the unique cellular and molecular
setting of the presenescence stage. It is hypothesised that
telomere dysfunction causing DDR and temporary activa-
tion of self-renewal on a background of insuﬃcient activity
of senescence inducers may allow putative adult stem cells to
overcome the G1 tetraploidy limit controlled by p53 leading
to their replicative stress and aberrant divisions. This would
favour acquisition of CIN, aneuploidy, and tumorigenic
mutations, thereby driving tumorigenesis.
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